Department of Environmental Biochemistry, ICMR-National Institute for Research in Environmental Health, Bhopal 462030, India.
Diagnostic Laboratory, DBT-National Institute of Animal Biotechnology, Hyderabad 500032, India.
Biosci Rep. 2021 Aug 27;41(8). doi: 10.1042/BSR20211238.
Coronavirus disease 2019 (COVID-19) is a life-threatening respiratory infection caused by severe acute respiratory syndrome virus (SARS-CoV-2), a novel human coronavirus. COVID-19 was declared a pandemic by World Health Organization in March 2020 for its continuous and rapid spread worldwide. Rapidly emerging COVID-19 epicenters and mutants of concerns have created mammoth chaos in healthcare sectors across the globe. With over 185 million infections and approximately 4 million deaths globally, COVID-19 continues its unchecked spread despite all mitigation measures. Until effective and affordable antiretroviral drugs are made available and the population at large is vaccinated, timely diagnosis of the infection and adoption of COVID-appropriate behavior remains major tool available to curtail the still escalating COVID-19 pandemic. This review provides an updated overview of various techniques of COVID-19 testing in human samples and also discusses, in brief, the biochemical composition and mode of transmission of the SARS-CoV-2. Technological advancement in various molecular, serological and immunological techniques including mainly the reverse-transcription polymerase chain reaction (RT-PCR), CRISPR, lateral flow assays (LFAs), and immunosensors are reviewed.
2019 年冠状病毒病(COVID-19)是由严重急性呼吸系统综合征冠状病毒 2(SARS-CoV-2)引起的危及生命的呼吸道感染,这是一种新型人类冠状病毒。由于其在全球范围内的持续快速传播,世界卫生组织于 2020 年 3 月宣布 COVID-19 为大流行。快速出现的 COVID-19 中心和令人关注的突变体在全球范围内的医疗保健部门造成了巨大的混乱。尽管采取了所有缓解措施,但全球仍有超过 1.85 亿例感染和大约 400 万人死亡。在有效且负担得起的抗逆转录病毒药物问世并为广大人群接种疫苗之前,及时诊断感染并采取 COVID-19 适当的行为仍然是遏制仍在升级的 COVID-19 大流行的主要手段。这篇综述提供了人类样本中 COVID-19 检测的各种技术的最新概述,并简要讨论了 SARS-CoV-2 的生化组成和传播方式。主要包括逆转录聚合酶链反应(RT-PCR)、CRISPR、侧向流动测定(LFA)和免疫传感器在内的各种分子、血清学和免疫学技术的技术进步都进行了回顾。